CBUS Cibus, Inc.

1.620USD+3.18%Mkt Cap: 123.81M $P/E: —

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides…

Key Statistics

Company
Market Cap123.81M USD
Enterprise Value385.83M USD
Revenue (TTM)4.35M USD
Gross Profit3.64M USD
Net Income (TTM)-127.08M USD
Revenue/Share0.07 USD
Last Price1.620 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees118
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.47
PEG—
EV/EBITDA-7.89
EV/Revenue88.76
P/S27.60
P/B8.09
EPS (TTM)-1.53
EPS (Forward)-0.64
52W Range
1.09017% of range4.191
52W High4.191 USD
52W Low1.090 USD
Profitability
Gross Margin100.00%
Oper. Margin-1300.30%
EBITDA Margin0.00%
Profit Margin-3492.31%
ROE-582.18%
ROA-41.66%
Growth
Revenue Growth6.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-50.59M USD
CapEx (TTM)578.00K USD
FCF Margin-1206.85%
FCF Yield-42.37%
Net Debt265.83M USD
Net Debt/EBITDA-5.44
Balance Sheet
Debt/Equity1.51
Current Ratio1.62
Quick Ratio1.49
Book Value/Sh0.19 USD
Cash/Share0.27 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Splits
Last Split1:5
Split DateJun 1, 2023
Analyst Consensus
Rating—
Target (Mean)14.33 USD
Upside (mean)+784.8%
Target Range2.000 USD – 25.00 USD
2.000+784.8% to mean25.00
# Analysts3
Ownership
Shares Out.76.43M
Float57.24M
Insiders26.10%
Institutions29.15%
Short Interest
Short Ratio31.9d
Short % Float6.06%
Short % Out.4.52%
Shares Short3.45M
Short (prev mo.)3.39M
Technical
SMA 501.692 (-4.2%)
SMA 2001.888 (-14.2%)
Beta1.57
S&P 52W Chg16.45%
Avg Vol (30d)121.85K
Avg Vol (10d)156.55K
Technical Indicators
RSI (14)50.2
MACD-0.0133
MACD Signal-0.0297
MACD Hist.+0.0164
BB Upper1.698 USD
BB Middle1.579 USD
BB Lower1.460 USD
BB Width15.06%
ATR (14)0.1253 USD
Vol Ratio (20d)0.79x